Search by Drug Name or NDC
NDC 62135-0968-41 Griseofulvin 125 mg/5mL Details
Griseofulvin 125 mg/5mL
Griseofulvin is a ORAL SUSPENSION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Chartwell RX, LLC.. The primary component is GRISEOFULVIN.
MedlinePlus Drug Summary
Griseofulvin is used to treat skin infections such as jock itch, athlete's foot, and ringworm; and fungal infections of the scalp, fingernails, and toenails. This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
Related Packages: 62135-0968-41Last Updated: 12/01/2022
MedLinePlus Full Drug Details: Griseofulvin
Product Information
| NDC | 62135-0968 |
|---|---|
| Product ID | 62135-968_f049ba4a-af6b-c769-e053-2a95a90aec9c |
| Associated GPIs | 11000030101805 |
| GCN Sequence Number | 009517 |
| GCN Sequence Number Description | griseofulvin, microsize ORAL SUSP 125 MG/5ML ORAL |
| HIC3 | W3A |
| HIC3 Description | ANTIFUNGAL ANTIBIOTICS |
| GCN | 42390 |
| HICL Sequence Number | 004126 |
| HICL Sequence Number Description | GRISEOFULVIN, MICROSIZE |
| Brand/Generic | Generic |
| Proprietary Name | Griseofulvin |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Griseofulvin (microsize) |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | SUSPENSION |
| Route | ORAL |
| Active Ingredient Strength | 125 |
| Active Ingredient Units | mg/5mL |
| Substance Name | GRISEOFULVIN |
| Labeler Name | Chartwell RX, LLC. |
| Pharmaceutical Class | Decreased Mitosis [PE], Microtubule Inhibition [PE], Tubulin Inhibiting Agent [EPC] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA065200 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 62135-0968-41 (62135096841)
| NDC Package Code | 62135-968-41 |
|---|---|
| Billing NDC | 62135096841 |
| Package | 120 mL in 1 BOTTLE (62135-968-41) |
| Marketing Start Date | 2021-08-26 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.36423 |
| Pricing Unit | ML |
| Effective Date | 2022-11-23 |
| NDC Description | GRISEOFULVIN 125 MG/5 ML SUSP |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1, 5 |
| Classification for Rate Setting | G |
| As of Date | 2022-11-23 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis